Your browser doesn't support javascript.
loading
Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
Berndtsson, Maria; Zetterberg, Eva; Holmström, Margareta; Mahmoud Hourani Soutari, Nida; Mikovic, Danijela; Elezovic, Ivo; Antovic, Jovan P.
Afiliação
  • Berndtsson M; Institute for Molecular Medicine and Surgery and Department of Clinical Chemistry, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden. Electronic address: mberndtsson@live.se.
  • Zetterberg E; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Holmström M; Coagulation Unit, Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Mahmoud Hourani Soutari N; Institute for Molecular Medicine and Surgery and Department of Clinical Chemistry, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • Mikovic D; Hemostasis Department and Hemophilia Center, Blood Transfusion Institute of Serbia, Serbia.
  • Elezovic I; Clinical Center of Serbia & Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Antovic JP; Institute for Molecular Medicine and Surgery and Department of Clinical Chemistry, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Thromb Res ; 144: 133-5, 2016 Aug.
Article em En | MEDLINE | ID: mdl-27331346
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Coagulantes / Hemofilia A / Hemostasia Limite: Humans Idioma: En Revista: Thromb Res Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Coagulantes / Hemofilia A / Hemostasia Limite: Humans Idioma: En Revista: Thromb Res Ano de publicação: 2016 Tipo de documento: Article